… accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID … . Cambridge, Massachusetts-based Alnylam first sued Moderna for patent infringement in 2022 … last year. Alnylam has also filed separate ongoing patent lawsuits over Pfizer …

… soon found itself facing patent infringement lawsuits from biopharma … agreed to resolve lawsuits Alnylam brought against Moderna for … in Delaware federal court. Alnylam filed its first infringement … was later consolidated into Alnylam's first infringement …

… mNexspike after leveling initial patent infringement claims against Moderna’ … drugmaker holds U.S. patents on lipid mRNA vaccine … content of” GSK’s patents within its own intellectual … mRNA players, such as Alnylam, Acuitas Therapeutics and Arbutus …

… 2035, although that polymorph patent is being challenged, the … The initial launch of Alnylam’s RNA interference therapy Amvuttra … in the second quarter, Alnylam shared in its earnings … by a healthcare professional. Alnylam has also noted some combination …

… for innovative treatments, Alnylam’s recent performance highlights … the competitive landscape. Alnylam Pharmaceuticals stock is surging … Moderna Beats Alnylam Appeal In COVID Vaccine Patent Case The … guidance,” Greenstreet added. Alnylam raised its fiscal 2025 …

… , both owned by Alnylam Pharmaceuticals, Inc. The asserted patents relate to biodegradable … , Alnylam argued that the district court erred in finding that the patentee … patent specification should not override the ordinary meaning of “branched alkyl.” Alnylam …

… Federal Circuit Opinions 1.   ALNYLAM PHARMACEUTICALS, INC. v. MODERNA … LABORATORIES LICENSING CORPORATION v. UNIFIED PATENTS, LLC [OPINION] (2023- … Board declined to adjudicate patent owner’s contention that … . And while the patent in Amgen required painstaking …

… and Hughes. Alnylam sued Moderna for infringement of two patents directed to … claim term “branched alkyl.” The patent specification states: “Unless otherwise specified … judgment of noninfringement. Alnylam appealed. On appeal, Alnylam argued that the district …

… does not infringe two patents owned by Alnylam Pharmaceuticals, upholding a prior … structures. Upon grant, Alnylam immediately enforced the two patents against Moderna, alleging … did not infringe the asserted patents. Alnylam appealed, arguing that the record …

… vaccine did not infringe Alnylam Pharmaceuticals’ U.S. Patent Nos. 11,246 … , the Court rejected Alnylam’s argument that the patent “otherwise specified” an … alternative definition.  For example, Alnylam argued …